Concepedia

Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes

Domizia Baldassi, Shubhankar Ambike, Martin Feuerherd, Cho‐Chin Cheng, David J. Peeler, Daniel P. Feldmann, Diana Porras-Gonzalez, Xin Wei, Lea-Adriana Keller, Nikolaus Kneidinger,

Journal of Controlled Release · 2022 · 44 citations · 36 references

DOIFull text

Open access

Concepts

References

36

Clinical Characteristics of Coronavirus Disease 2019 in China

Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · New England Journal of Medicine · 2020 · 31.2K citations · Full text

, , +10

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al. · Cell · 2020 · 21.4K citations · Full text

, , +11

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

Yeming Wang, Dingyu Zhang, Guanhua Du et al. · The Lancet · 2020 · 3.7K citations · Full text

, , +4

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

Angélica Jayk Bernal, Monica Maria Gomes da Silva, Dany Badibanga Musungaie et al. · New England Journal of Medicine · 2021 · 1.9K citations · Full text

, , +16

SARS‐CoV‐2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

Soeren Lukassen, Robert Lorenz Chua, Timo B. Trefzer et al. · The EMBO Journal · 2020 · 1K citations · Full text

, , +17